Bontemps, Andrew P and Hawes, Elizabeth S and Pridgen, Bailey E and Wagner, William P and Black, Dominique and Cropsey, Karen L (2026) Cannabis use within the United States: prevalence of cannabis use by state legal status and perceptions of benefit and harm. Drug and Alcohol Dependence Reports , 19 .

Graham, Myfanwy and Assefa, Dereje and Cong-Lem, Ngo and Nielsen, Suzanne (2026) Higher THC concentration medicinal cannabis products efficacy and safety considerations: a rapid review. Drug and Alcohol Review , 45 , (4) .

[Oireachtas] Dáil Éireann debate. Question 447, 448, 449 – Customs and excise [Tobacco] [28732/26, 28733/26, 28735/26]. (21 Apr 2026)

Dillon, Lucy (2026) The 68th session of the Commission on Narcotic Drugs. Drugnet Ireland , Issue 93, February 2026 , pp. 12-13.

Trice, Catharine and Prebihalo, Sarah and Rattan, Saniya and Spencer, Kara and Karasick, Andrew and Scott-Richardson, Maya and Punzalan, Cecile and Gensheimer, Kathleen and Markon, André and South, Erin M and Bersoff-Matcha, Susan and Vasisht, Kaveeta and Wolpert, Beverly J (2026) Cannabinoid use among adult women: a scoping review. Journal of Women's Health , 35 , (3) , pp. 271-289.

Metrik, Jane and Aston, Elizabeth R and Gunn, Rachel L and Swift, Robert and MacKillop, James and Kahler, Christopher W (2026) Acute effects of cannabis on alcohol craving and consumption: a randomized controlled crossover trial. The American Journal of Psychiatry , 183 , (2) , pp. 134-143.

Uporova, Julia and Peacock, Amy and Sutherland, Rachel (2026) Prescribed cannabis and driving behaviours among two samples of people who regularly use illicit drugs, 2025. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney.

Metrik, Jane and Bush, Nicholas and Gunn, Rachel L and McCarthy, Denis M (2026) Recent advances in the science of cannabis-impaired driving. Current Addiction Reports , 13 .

Central Intelligence Agency. (2026) The world factbook. Field listing: illicit drugs. URL: https://www.cia.gov/the-world-factbook/field/illic...

McDonald, André J and Doggett, Amanda and Bondy, Susan J and Colman, Ian and Cook, Steven and Hamilton, Hayley A and Kurdyak, Paul and Leatherdale, Scott T and Myran, Daniel T and Rehm, Jürgen and Wickens, Christine M and MacKillop, James and Halladay, Jillian (2026) Adolescent cannabis use and psychological distress from 2013 to 2023: a population-based study in Ontario, Canada. Addiction , Early online .

Ateş, Gülay and Welsch, Patrick and Klose, Petra and Phillips, Tudor and Lambers, Britta and Häuser, Winfried and Radbruch, Lukas (2026) Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews , 1 , (1) .

Lees Thorne, Rachel and Lawn, Will and Petrilli, Kat and Trinci, Katie and Borissova, Anya and Ofori, Shelan and Mokrysz, Claire and Curran, H Valerie and Hines, Lindsey A and Freeman, Tom P (2026) Estimating thresholds for risk of cannabis use disorder using standard delta-9-tetrahydrocannabinol (THC) units. Addiction , Early online .

Canadian Centre on Substance Use and Addiction. (2026) Addressing cannabis hyperemesis syndrome in Canada. Ottawa: Canadian Centre on Substance Use and Addiction.

Medical Bureau of Road Safety. (2025) Medical Bureau of Road Safety annual report 2024. Dublin: Medical Bureau of Road Safety.

Wilkinson, Emma (2025) The rise of nitazenes: what pharmacists need to know. The Pharmacist .

[Oireachtas] Dáil Éireann Debate. Question 389 – Customs and excise [vape products] [61349/25]. (12 Nov 2025)

Oz, Esin and Kasikci, Merve and Celik, İbrahim and Gurler, Mukaddes (2025) Metabolic profile of male cannabis users and estimation of candidate biomarkers. Chemical Research in Toxicology , 38 , (10) , pp. 1762-1770.

Spinazzola, Edoardo and Degen, Hannah and Austin-Zimmerman, Isabelle and Trotta, Giulia and Chesney, Edward and Li, Zhikun and Alameda, Luis and Leung, Bok Man and Lang, Yifei and Quattrone, Andrea and Quattrone, Diego and Castrignanò, Erika and Wolff, Kim and Murray, Robin and Freeman, Tom P and Di Forti, Marta (2025) Are reasons for first using cannabis associated with subsequent cannabis consumption (standard THC units) and psychopathology? BMJ Mental Health , 28 .

Li, Sophie and Solmi, Marco and Myran, Daniel T and Fabiano, Nicholas (2025) Cannabis and psychosis. Canadian Medical Association Journal , 197 , (27) .

Trotta, Giulia and Spinazzola, Edoardo and Degen, Hannah and Li, Zhikun and Austin-Zimmerman, Isabelle and Leung, Bok Man and Lang, Yifei and Rodriguez, Victoria and Aas, Monica and Sideli, Lucia and Wolff, Kim and Freeman, Tom P and Murray, Robin M and Wong, Chloe C Y and Alameda, Luis and Di Forti, Marta (2025) The impact of childhood trauma and cannabis use on paranoia: a structural equation model approach. Psychological Medicine , 55 .

Ireland. Department of Health. (2025) HHC (Hexahydrocannabinol). Dublin: Department of Health.

[Oireachtas] Dáil Éireann debate. Question 2604 – Departmental regulations [THC products] [41090/25]. (29 Jul 2025)

Dooley, Aileen (2025) HSE drugs and alcohol helpline and the HSE HIV and sexual health helpline annual report 2024. Dublin: Health Service Executive.

European Union Drugs Agency. (2025) European drug report 2025: trends and developments. Lisbon: European Union Drugs Agency.

National Drug and Alcohol Research Centre. (2025) NDARC fact sheet: cannabis. Sydney: National Drug and Alcohol Research Centre.

Lees, Rachel and Lawn, Will and Petrilli, Kat and Brown, Amelia and Trinci, Katie and Borissova, Anya and Ofori, Shelan and Mokrysz, Claire and Curran, H Valerie and Hines, Lindsey A and Freeman, Tom P (2025) Persistent increased severity of cannabis use disorder symptoms in adolescents compared to adults: a one-year longitudinal study. European Archives of Psychiatry and Clinical Neuroscience , 275 , pp. 397-406.

Shafie, Mahan and Ing, Kevin and Rostam-Abadi, Yasna and Weleff, Jeremy and Griffin, Mackenzie and Ranganathan, Mohini and Mohammad Aghaei, Ardavan and Pratt, Nicholas and Funaro, Melissa C and Bassir Nia, Anahita (2025) The potential use of cannabidiol in the treatment of opioid use disorder: a systematic review. Addiction Biology , 30 , (5) .

Advisory Council on the Misuse of Drugs. (2025) ‘Semi-synthetic’ cannabinoids: cannabinoids related to tetrahydro- cannabinol and cannabidiol. London: Advisory Council on the Misuse of Drugs.

[Oireachtas] Dáil Éireann debate. Questions 341, 691 – Cannabis for medicinal use [Cannabinoids] [16274/25, 15652/25]. (02 Apr 2025)

de Bode, Nora and Kroon, Emese and Sznitman, Sharon R and Cousijn, Janna (2025) The differential effects of medicinal cannabis on mental health: a systematic review. Clinical Psychology Review , 118 .

Millar, Seán (2025) Psychotic illness triggered by widely available semi-synthetic cannabinoid. Drugnet Ireland , Issue 90, Winter 2025 , p. 15.

Pourebrahim, Sepehr and Ahmad, Tooba and Rottmann, Elisabeth and Schulze, Johannes and Scheller, Bertram (2025) Does cannabis use contribute to schizophrenia? A causation analysis based on epidemiological evidence. Biomolecules , 15 , (3) .

Arlen, Maddison T and Patterson, Stephanie J and Page, Michelle K and Liu, Rui and Caruana, Vincenza and Wilson, Emily T and Laporte, Stéphane A and Goniewicz, Maciej L and Harris, Cory S and Eidelman, David H and Baglole, Carolyn J (2025) Cannabis vaping elicits transcriptomic and metabolomic changes involved in inflammatory, oxidative stress, and cancer pathways in human bronchial epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology , 328 , (3) , L478-L496.

Gardner, Matthew and Bowden, Celeste and Manzoor, Shoaib and Cozier, Gyles E and Andrews, Rachael C and Craft, Sam and Skumlien, Martine and Sunderland, Peter and Tooth, Tom and Collins, Peter and Power, Alexander and Haines, Tom SF and Freeman, Tom P and Scott, Jennifer and Sutcliffe, Oliver B and Bowman, Richard W and Husbands, Stephen M and Pudney, Christopher R (2025) Field-portable device for detection of controlled and psychoactive substances from e-cigarettes. ACS Omega , 10 , (8) , pp. 7839-7847.

Albrecht, Matthew A and Hasan, Razi and Kekez, Damir and Zhou, Huaqiong (2025) Dose-response relationship between blood concentrations of THC and crash culpability risk: an updated meta-regression of culpability studies. Drug Science, Policy and Law , 11 .

[Oireachtas] Dáil Éireann debate. Question 220, 205 – Healthcare policy [3906/25] Agriculture industry [Hemp] [3907/25]. (06 Feb 2025)

Burmeister, James R and Jung, John K (2025) High risk, low key: the new face of drug use. Substance Use : Research and Treatment , 19 .

European Union Drugs Agency. (2025) Synthetic cannabinoids. URL: https://www.euda.europa.eu/topics/synthetic-cannab...

Chesney, Edward and Oliver, Dominic and Sarma, Ananya and Lamper, Ayşe Doğa and Slimani, Ikram and Lloyd, Millie and Dickens, Alex M and Welds, Michael and Kråkström, Matilda and Gasparini-Andre, Irma and Orešič, Matej and Lawn, Will and Babayeva, Natavan and Freeman, Tom P and Englund, Amir and Strang, John and McGuire, Philip (2025) Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial. Neuropsychopharmacology , 50 , pp. 1759-1767.

Cozier, Gyles E and Gardner, Matthew and Craft, Sam and Skumlien, Martine and Spicer, Jack and Andrews, Rachael and Power, Alexander and Haines, Tom and Bowman, Richard and Manley, Amy E and Sunderland, Peter and Sutcliffe, Oliver B and Husbands, Stephen M and Hines, Lindsey and Taylor, Gillian and Freeman, Tom P and Scott, Jennifer and Pudney, Christopher R (2025) Synthetic cannabinoids in e-cigarettes seized from English schools. Addiction , 120 , (10) , pp. 1995-2004.

Granville, Ashely and Grigg, Jodie and Kowalski, Michala and Sevigny, Eric and Zobel, Frank and Fortin, Davide (2024) What can we learn from low-THC cannabis growers in Europe? A comparative transnational study of small-scale cannabis growers from Italy and Switzerland. International Journal of Drug Policy , 144 , (3) .

Wood, Shea and Gabrys, Robert (2024) A standard THC unit in Canada. Recommendations for implementation. Ottawa: Canadian Centre on Substance Use and Addiction.

Crew. (2024) THC vapes. Edinburgh: CREW.

Tort, Sera and Husein-ElAhmed, Husein (2023) Clinical question: For adults with opioid‐refractory cancer pain, what are the benefits and harms of nabiximols (tetrahydrocannabinol (THC) and cannabidiol (CBD))? Cochrane Clinical Answers .

Lin, Lin and Jung, Kwang-Mook and Lee, Hye-Lim and Le, Johnny and Colleluori, Georgia and Wood, Courtney and Palese, Francesca and Squire, Erica and Ramirez, Jade and Su, Shiqi and Torrens, Alexa and Fotio, Yannick and Tang, Lingyi and Yu, Clinton and Yang, Qin and Huang, Lan and DiPatrizio, Nicholas and Jang, Cholsoon and Cinti, Saverio and Piomelli, Daniele (2023) Adolescent exposure to low-dose THC disrupts energy balance and adipose organ homeostasis in adulthood. Cell Metabolism .

Englund, Amir and Oliver, Dominic and Chesney, Edward and Chester, Lucy and Wilson, Jack and Sovi, Simina and De Micheli, Andrea and Hodsoll, John and Fusar-Poli, Paolo and Strang, John and Murray, Robin M and Freeman, Tom P and McGuire, Philip (2023) Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios. Neuropsychopharmacology , 48 , pp. 869-876.

[thejournal.ie] , O'Faolain, Aodhan Court dismisses challenge to ban on selling products containing THC. (09 Nov 2022)

Food Safety Authority of Ireland. Recall of certain batches of CBD and hemp oil products due to the presence of unsafe levels of delta‐9‐tetrahydrocannabinol (THC). (14 Jul 2022)

Wurz, Gregory T and DeGregorio, Michael W (2022) Indeterminacy of cannabis impairment and ∆-tetrahydrocannabinol (∆-THC) levels in blood and breath. Scientific Reports , 12 .

Goodman, Samantha and Hammond, David (2022) THC labeling on cannabis products: an experimental study of approaches for labeling THC servings on cannabis edibles. Journal of Cannabis Research , 4 .

Hemp Federation Ireland. (2022) EU Commission clarifies the legality of THC in hemp food. Dublin: Hemp Federation Ireland.

Fearby, Nathan and Penman, Samantha and Thanos, Panayotis (2022) Effects of Δ9-Tetrahydrocannibinol (THC) on obesity at different stages of life: a literature review. International Journal of Environmental Research and Public Health , 19 , (6) .

[Food Safety Authority of Ireland] Recall of certain batches of Kama Hemp Kama artisan coffee due to the presence of unsafe levels of Delta‐9‐tetrahydrocannabinol (THC). (20 Jan 2022)

[Irish Examiner] , O'Rourke, Ryan Warnings over dangers of 'fake' THC edibles. (04 Oct 2021)

[Food Safety Authority of Ireland] Recall of various CBD food supplements due to the presence of unsafe levels of delta‐9‐tetrahydrocannabinol (THC). (27 Jul 2021)

Kuzma-Hunt, Alexander G and Truong, Vivien B and Favetta, Laura A (2021) Glucocorticoids, stress and delta-9 tetrahydrocannabinol (THC) during early embryonic development. International Journal of Molecular Sciences , 22 , (14) .

[Independent.ie] , Bracken, Ali Cannabis edibles: Dublin principals warn parents that THC jellies are being sold in some schools. (13 Jun 2021)

Freeman, Tom P and Craft, Sam and Wilson, Jack and Stylianou, Stephan and ElSohly, Mahmoud and Di Forti, Marta and Lynskey, Michael T (2021) Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis. Addiction , 116 , (5) , pp. 1000-1010.

McCartney, Danielle and Arkell, Thomas R and Irwin, Christopher and McGregor, Iain S (2021) Determining the magnitude and duration of acute Δ-tetrahydrocannabinol (Δ-THC)-induced driving and cognitive impairment: a systematic and meta-analytic review. Neuroscience and Biobehavioral Reviews , 126 , pp. 175-193.

Leung, Janni and Stjepanović, Daniel and Dawson, Danielle and Hall, Wayne D (2021) Do cannabis users reduce their THC dosages when using more potent cannabis products? A review. Frontiers in Psychiatry , 12 , p. 630602.

European Monitoring Centre for Drugs and Drug Addiction. (2020) Low-THC cannabis products in Europe. Luxembourg: Publications Office of the European Union.

Jones, Éamon and Vlachou, Styliani (2020) A critical review of the role of the cannabinoid compounds Δ-tetrahydrocannabinol (Δ-THC) and cannabidiol (CBD) and their combination in multiple sclerosis treatment. Molecules , 25 , (21) .

Poyatos, Lourdes and Pérez-Acevedo, Ana Pilar and Papaseit, Esther and Pérez-Mañá, Clara and Martin, Soraya and Hladun, Olga and Siles, Adrià and Torrens, Marta and Busardo, Francesco Paolo and Farré, Magí (2020) Oral administration of cannabis and Δ-9-tetrahydrocannabinol (THC) preparations: a systematic review. Medicina , 56 , (6) .

[FSAI Ireland] Recall of EUPHORIA CBD Full Spectrum Oil products due to the presence of THC, an unauthorised substance. (16 Jul 2019)

[Oireachtas] Dail Eireann debate. Questions on promised legislation [THC]. (30 May 2019)

National Centre for Pharmacoeconomics. (2013) Delta-9-tetrahydrocannabinol (THC) /Cannabidiol (CBD) (Sativex®). Dublin: National Centre for Pharmacoeconomics.

Forensic Science Laboratory. Arnold, Colette (2011) The potency of THC in Cannabis products. Dublin: National Advisory Committee on Drugs.